Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 31
1
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

How have genetics of African Lions changed over the last century?

In this study, we will compare genetic information from 100-year-old lions preserved in museums to modern lions...

Is habitat quality a key factor in determining whether koalas develop chlamydial disease?

Northern koala populations have declined rapidly in the last two decades and localised extinctions are predicted...

Thermolyze: A Temperature Controlled Kill-Switch for Containment of Pathogenic Bacteria in Research Labs

We will engineer a temperature-controlled kill switch to be used in pathogenic or genetically modified bacteria...

Backer Badge Funded